A Phase 1 Study of the Pharmacokinetics, Safety, and Tolerability of Posdinemab (JNJ‐63733657) in Healthy Chinese Adults

Documenti analoghi

• Pharmacokinetics, Safety, and Tolerability of Cedirogant in Healthy Japanese and Chinese Adults
  di: Mohamed‐Eslam F Mohamed, et al.
  Pubblicazione: (2024)
• Safety, Tolerability, and Pharmacokinetics of Voriconazole for Injection in Two Preparations in Chinese Healthy Adult Volunteers
  di: Jin Yu, et al.
  Pubblicazione: (2024)
• Intravenous Ganaxolone: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability in Healthy Adults
  di: Maciej Gasior, et al.
  Pubblicazione: (2024)
• Pharmacokinetics, Safety, and Tolerability of Single‐Dose Dazukibart in Healthy Adults in China and Japan: Results From 2 Randomized, Double‐Blind, Phase 1 Studies
  di: Naihan Chen, et al.
  Pubblicazione: (2025)
• Safety, Tolerability, and Pharmacokinetics of Galcanezumab, an Anti‐CGRP Antibody, in Healthy Chinese Participants
  di: Jingjing Wang, et al.
  Pubblicazione: (2025)